title: Nifuroxazide: licence modification. New restrictions in children.
abstract: It would be best simply not to use nifuroxazide, an antibacterial agent with no proven specific clinical action. Oral rehydration remains the cornerstone of treatment in this setting.
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002662:Child Health Services; D002675:Child, Preschool; D000075202:Contraindications; D003967:Diarrhea / Q000188:drug therapy*; D017277:Drug Approval; D005440:Fluid Therapy; D005602:France; D006801:Humans; D062385:Hydroxybenzoates / Q000627:therapeutic use; D007223:Infant; D009581:Nitrofurans / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D062385:Hydroxybenzoates; D009581:Nitrofurans